Optometry - Journal of the American Optometric Association
Volume 81, Issue 8 , Pages 394-404 , August 2010

Palinopsia

  • Brian Abert, O.D.

      Affiliations

    • Vista Eye Care, Thornton, Colorado
    • Corresponding Author InformationCorresponding author: Brian Abert, O.D., Vista Eye Care, 4243 E. 136th St., Suite #342, Thornton, Colorado 80602.
  • ,
  • Pauline F. Ilsen, O.D.

      Affiliations

    • Department of Veterans Affairs Optometry, Los Angeles, California

References 

  1. Critchley M. Types of visual perseveration: “Palinopsia” and “illusory visual spread”. Brain. 1951;74:267–299
  2. Bender MB, Feldman M, Sobin AJ. Palinopsia. Brain. 1968;91:321–338
  3. Kawasaki A, Purvin V. Persistent palinopsia following ingestion of lysergic acid diethylamide (LSD). Arch Ophthal. 1996;114:47–50
  4. Hughes MS, Lessell S. Trazodone-induced palinopsia. Arch Ophthalmol. 1990;108:399–400
  5. Meadows JC, Munro SSF. Palinopsia. J Neuro Psych. 1977;40:5–8
  6. Lefèbre C, Kölmel HW. Palinopsia as an epileptic phenomenon. Eur Neurol. 1989;29:323–327
  7. Sun Y, Lin CK. Sequential appearance and disappearance of hemianopia, palinopsia and metamorphopsia: a case report and literature review. Acta Neurologica Taiwanica. 2004;13:77–83
  8. Michel EM, Troost BT. Palinopsia: Cerebral localization with computed tomography. Neurology. 1980;30:887–889
  9. Muller T, Büttner T, Kuhn W, et al. Palinopsia as a sensory epileptic phenomenon. Acta Neurol Scand. 1995;91:433–436
  10. Purvin V, Bonnin J, Goodman J. Palinopsia as a presenting manifestation of Creutzfeldt-Jakob Disease. J Clin Neuro-ophthalmol. 1989;9:242–246
  11. Fournier AV, Zackon DH. Palinopsia: a case report and review of the literature. Can J Ophthalmol. 2000;35:154–157
  12. Kinsbourne M, Warrington EK. A study of visual perseveration. J Neurol Neurosurg Psychiatry. 1963;26:468–475
  13. Evans RW. Topiramate. Reactions. 2006;1105:18
  14. Faber RA, Benzick JM. Nefazodone-induced palinopsia. J Clin Psychopharmacol. 2000;20:275–276
  15. Ihde-Scholl T, Jefferson JW. Mirtazapine-associated palinopsia. J Clin Psychiatry. 2001;62:373
  16. Pomeranz HD, Lessel S. Palinopsia and polyopia in the absence of drugs or cerebral disease. Neurology. 2000;54:855–859
  17. Sierra M, Berrios GE. Flashbulb memories and other repetitive images: a psychiatric perspective. Comp Psych. 1999;40:115–125
  18. Schultz J, Videbeck SL. Lippincott's manual of psychiatric nursing care plans, edition 8, revised. Philadelphia, PA: Lippincott Williams & Wilkins; 2008;169
  19. Bynke H. Visual perseveration following temporal lobe surgery. Neuro-ophthalmology. 1984;4:47–53
  20. Jacome DE. Palinopsia and bitemporal visual extinction on fixation. Ann Ophthalmol. 1985;17:251–252
  21. Purvin VA. Visual disturbance secondary to clomiphene citrate. Arch Ophthalmol. 1995;113:482–484
  22. Cummings JL, Syndulko K, Goldberg Z, et al. Palinopsia reconsidered. Neurology. 1982;32:444–447
  23. Young WB, Heros DO, Ehrenberg BL, et al. Metamorphopsia and palinopsia. Association with periodic lateralized epileptiform discharges in a patient with malignant astrocytoma. Arch Neurol. 1989;46:820–822
  24. Swash M. Visual perseveration in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 1979;42:569–571
  25. Ardila A, Botero M, Gomez J. Palinopsia and visual allesthesia. Intern J Neurosci. 1987;32:775–782
  26. Johnson SF, Loge RV. Palinopsia due to nonketotic hyperglycemia. West J Med. 1988;148:331–332
  27. Localisation of visual hallucinations. Br Med J. 1977;2:147–148
  28. Gates TJ, Stagno SJ, Gulledge AD. Palinopsia posing as psychotic depression. Br J Psychiatry. 1988;153:391–393
  29. Marneros A, Korner J. Chronic palinopsia in schizophrenia. Psychopathology. 1993;26:236–239
  30. Shimojo S, Kamitani Y, Nishida S. Afterimage of perceptually filled-in surface. Science. 2001;293:1677–1680
  31. Goldstein MA, Silverman ME, Wang AK, et al. An fMRI study of the neural mechanisms of palinopsia. Neuropsychiatry Clin Neurosci. 2007;19:223–224
  32. Blythe IM, Bromley JM, Ruddock KH, et al. A study of systematic visual perseveration involving central mechanisms. Brain. 1986;109:661–675
  33. Vaphiades MS, Celesia GG, Brigell MG. Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways. Neurology. 1996;47:408–417
  34. Lance JW. Simple formed hallucinations confined to the area of a specific visual field defect. Brain. 1976;99:719–734
  35. Lazaro RP. Palinopsia: rare but ominous symptom of cerebral dysfunction. Neurosurgery. 1983;13:310–313
  36. Werring DJ, Marsden CD. Visual hallucinations and palinopsia due to an occipital lobe tuberculoma. J Neurol Neurosurg. 1999;5:684
  37. Lunardi P, Tacconi L, Missori P, et al. Palinopsia: unusual presenting symptom of a cerebral abscess in a man with Kartagener's syndrome. Clin Neurol Neurosurg. 1991;93:337–339
  38. Ogunyemi A, Adams D. Migraine-like symptoms triggered by occipital lobe seizures: response to sumatriptan. Can J Neurol Sci. 1998;25:151–153
  39. Patterson MC, Bunce IH, Eadie MJ. Cerebral abscess in leukaemia: an unusual presentation of a rare complication. Clin Exp Neurol. 1985;21:257–262
  40. Abdulfattah Q, Swanson JW. Migraine headache and palinopsia. Headache. 2005;45:836
  41. Killer HE, Buettner UW. Multiple visual hallucinations and pseudo hallucinations in one individual patient. Ophthalmologica. 2005;219:115–118
  42. Landis T, Cummings JL, Benson DF, et al. Loss of topographic familiarity. Arch Neurol. 1986;43:132–136
  43. Evans RW. Reversible palinopsia and the Alice in Wonderland syndrome associated with topiramate use in migraineurs. Headache. 2006;46:815–818
  44. Engelsen BA, Tzoulis C, Karlsen B, et al. POLGI mutations cause a syndromic epilepsy with occipital lobe predilection. Brain. 2008;131:818–828
  45. Jacobs L, Feldman M, Bender MB. The persistence of visual or auditory percepts as symptoms of irritative lesions of the cerebrum of man. Z Neurol. 1972;203:211–218
  46. Kupersmith MJ, Berenstein A, Nelson PK, et al. Visual symptoms with dural arteriovenous malformations draining into occipital veins. Neurology. 1999;52:156–162
  47. Smith PEM, Shah P, Sharpe J, et al. Palinopsia. Lancet. 2003;361:1098
  48. Cleland PG, Saunders M, Rosser R. An unusual case of visual perseveration. J Neurol Neuro Psychiatry. 1981;44:262–263
  49. Kondziella D, Maetzel H. The sting in the tail: syncope and palinopsia. J Neurol. 2006;253:657–658
  50. Santhouse AM, Howard RJ, ffytche DH. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain. 2000;123:2055–2064
  51. Hayashi R, Shimizu S, Watanabe R, et al. Palinopsia and perilesional hyperperfusion following subcortical hemorrhage. Acta Neurol Scand. 2002;105:228–231
  52. Cummings JL, Miller BL. Visual hallucinations: clinical occurrence and use in differential diagnosis. Western J Med. 1987;146:46–51
  53. Norton JW, Corbett JJ. Visual perceptual abnormalities: hallucinations and illusions. Seminars Neurol. 2000;20:111–121
  54. Schröter A, Zerr I, Henkel K, et al. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob Disease. Arch Neurol. 2000;57:1751–1757
  55. Joseph AB. Cotard's syndrome in a patient with coexistent Capgras' syndrome, syndrome of subjective doubles, and palinopsia. J Clin Psychiatry. 1986;47:605–606
  56. Friedman DI, Hu EH, Sadun AA. Neuro-ophthalmic complications of interleukin 2 therapy. Arch Ophthalmol. 1991;109:1679–1680
  57. Fontenelle LF. Topiramate-induced palinopsia. J Neuropsychiatry Clin Neurosci. 2008;20:249–250
  58. Rubin EH, de Alwis DP, Pouliquen I, et al. A phase I trial of a potent P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), administered orally in combination with doxorubicin in patients with advanced malignancies. Clin Cancer Res. 2002;8:3710–3717
  59. Lauterbach EC, Abdelhamid A, Annandale JB. Posthallucinogen-like visual illusions (palinopsia) with risperidone in a patient without previous hallucinogen exposure: possible relation to serotonin 5HT2a receptor blockade. Pharmacopsych. 2000;33:38–41
  60. Terao T. Palinopsia and paroxetine withdrawal. J Clin Psychiatry. 2002;63:368
  61. Hori H, Terao T, Nakamura J. Visual perseveration: a new side effect of maprotiline. Acta Psychiatr Scand. 2000;101:476–477
  62. Gaillard M, Borruat F. Persisting visual hallucinations and illusions in previously drug-addicted patients. Klin Monatsbl Augenheilkd. 2003;220:176–178
  63. McGuire PK, Cope H, Fahy TA. Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine (“ecstasy”). Br J Psychiatry. 1994;165:391–395
  64. Sunness JS. Persistent afterimages (palinopsia) and photophobia in a patient with a history of LSD use. Retina. 2004;5:805
  65. Horowitz MJ. Flashbacks: recurrent intrusive images after the use of LSD. Am J Psychiatry. 1969;126:565–569
  66. Abraham HD. Visual phenomenology of the LSD flashback. Arch Gen Psychiatry. 1983;40:884–889
  67. Serafetinides EA. The significance of the temporal lobes and of hemispheric dominance in the production of the LSD-25 symptomatology in man: a study of epileptic patients before and after temporal lobectomy. Neuropsychologia. 1965;3:69–79
  68. Lessell S. Higher disorders of visual function: positive phenomena. In:  Glaser JS,  Smith JL editor. Neuro-ophthalmology. St. Louis: CV Mosby; 1975;p. 27–44
  69. Álvaro L. Hallucinations and pathological visual perceptions in Maupassant's fantastical short stories—Neurological approach. J Hist Neurosciences. 2000;14:100–115
  70. Brasić JR. Hallucinations. Perceptual and Motor Skills. 1998;86:851–877
  71. Lee MS, Volpe NJ. Double vision. Curr Treat Options Neurol. 2001;3:383–388
  72. Silva JA, Tekell JL, Penny G, et al. Resolution of palinopsia with carbamazepine. J Clin Psychiatry. 1997;58:30

PII: S1529-1839(10)00257-5

doi: 10.1016/j.optm.2009.12.010

Optometry - Journal of the American Optometric Association
Volume 81, Issue 8 , Pages 394-404 , August 2010